by Brian D. Moseley, MD; John M. Stern, MD; and James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES
Improving the ability to gauge seizure risk and to forecast seizures for individuals with epilepsy is an unmet need and a growing area of research.......READ MORE
by Brian D. Moseley, MD; John M. Stern, MD; and James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES
Ease of administration and lower pill burdens are important factors that can aid in patient adherence. One of the most significant advances of the ......READ MORE
by James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES
Although the stigma of epilepsy has been reduced over the years, misconceptions about the disease remain. Even today, there is a general undercurre......READ MORE
For women with epilepsy, the availability of multiple options for antiepileptic drug (AED) therapy can offer flexibility when balancing the risks a......READ MORE
by James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES
Some studies indicate that the newer antiepileptic drugs (AEDs) do not interfere with learning, while others have found an association between some......READ MORE
Neurostimulation is receiving increasing attention, with growing recognition of the great potential to intervene on the brain networks involved in ......READ MORE
